One important metric to look for in a stock is an 80 or higher Relative Strength Rating. Tempus AI now clears that threshold, with a jump from 72 to 86 Monday.
This unique rating identifies market leadership by using a 1 (worst) to 99 (best) score that identifies how a stock's price action over the last 52 weeks matches up against other publicly traded companies.
Over 100 years of market history shows that the market's biggest winners typically have an RS Rating of over 80 in the early stages of their moves.
Hone Your Stock-Picking Skills By Focusing On These Factors
While it's not currently an ideal time to invest, see if the stock goes on to offer and clear a proper buy point.
The company reported 0% earnings growth in its most recent report, while sales growth came in at 36%.
Tempus AI holds the No. 11 rank among its peers in the Medical-Research Equipment/Services industry group. Veracyte, Natera and Medpace Holdings are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Which Stocks Are Showing Rising Relative Strength?
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
